Stay updated on FLYSYN-101 Clinical Trial in MRD Positive AML
Sign up to get notified when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.
Latest updates to the FLYSYN-101 Clinical Trial in MRD Positive AML page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section added, listing Baden-Wurttemberg and Lower Saxony as study sites. HHS Vulnerability Disclosure and location-specific pages for Baden-Wurttemberg and Lower Saxony were removed.SummaryDifference0.3%
- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.3.2 was added, replacing v3.3.1. No visible changes to the study page content or layout.SummaryDifference0.1%
- Check40 days agoChange DetectedAdded an editorial note that publications are provided voluntarily by the person entering information about the study and updated the revision tag to v3.3.1. The previous statement asserting that publications are about the study results was removed.SummaryDifference0.1%
- Check48 days agoChange DetectedRemoved the funding-lapse disclaimer banner from the study page, which previously warned that information may not be up to date.SummaryDifference0.4%
- Check62 days agoChange DetectedNo additions or deletions were detected in the page content.SummaryDifference0.5%
- Check91 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%
Stay in the know with updates to FLYSYN-101 Clinical Trial in MRD Positive AML
Enter your email address, and we'll notify you when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.